Cite
HARVARD Citation
Llanos-Cuentas, A. et al. (2018). Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Lancet infectious diseases. 18 (8), pp. 874-883. [Online].